Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children.

Source:http://linkedlifedata.com/resource/pubmed/id/19636278

Download in:

View as

General Info

PMID
19636278